Stereotactic ablative body radiotherapy for oligometastatic inguinal lymph node in castrate resistant prostate cancer

被引:0
|
作者
Goyal, Shikha [1 ]
Periasamy, Kannan [1 ]
Madan, Renu [1 ]
Vias, Poorva [1 ]
Chandran, Vigneshwaran [1 ]
机构
[1] Postgrad Inst Med Educ & Res, Dept Radiotherapy & Oncol, Chandigarh, India
关键词
METASTASIS;
D O I
10.1016/j.ajur.2021.12.004
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:109 / 112
页数:4
相关论文
共 50 条
  • [1] Local ablative stereotactic body radiotherapy for oligometastatic prostate cancer
    Niazi, Tamim
    Elakshar, Sara
    Stroian, Gabriela
    [J]. CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2018, 12 (03) : 351 - 358
  • [2] Stereotactic body radiotherapy in 117 oligometastatic lymph node recurrent prostate cancer patients
    Fanetti, G.
    Jereczek-Fossa, B. A.
    Fodor, C.
    Francia, C. M.
    Zerini, D.
    Surgo, A.
    Muto, M.
    Gerardi, M. A.
    Dicuonzo, S.
    Cambria, R.
    Garibaldi, C.
    Pansini, F.
    Bazani, A.
    De Cobelli, O.
    Orecchia, R.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S639 - S640
  • [3] Single-Fraction Stereotactic Body Radiotherapy for Oligometastatic Lymph Node Relapse in Prostate Cancer
    Loi, Mauro
    Di Cataldo, Vanessa
    Francolini, Giulio
    Bonomo, Pierluigi
    Masi, Laura
    Simontacchi, Gabriele
    Detti, Beatrice
    Greto, Daniela
    Desideri, Isacco
    Livi, Lorenzo
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 (11) : 703 - 705
  • [4] Stereotactic ablative Radiotherapy in Patients with oligometastatic Prostate Cancer
    Lorenz, Judith
    [J]. AKTUELLE UROLOGIE, 2021, 52 (01) : 22 - 22
  • [5] The what, when and how of stereotactic ablative body radiotherapy for oligometastatic prostate cancer
    Dreosti, Marcus
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 71 - 71
  • [6] Stereotactic ablative body radiotherapy (SAbR) for oligometastatic cancer
    Desai, Neil B.
    Laine, Aaron M.
    Timmerman, Robert D.
    [J]. BRITISH JOURNAL OF RADIOLOGY, 2017, 90 (1070):
  • [7] Salvage stereotactic body radiotherapy for lymph node oligorecurrent prostate cancer
    Fanetti, G.
    Fodor, C.
    Ciardo, D.
    Santoro, L.
    Francia, C. M.
    Muto, M.
    Surgo, A.
    Zerini, D.
    Marvaso, G.
    Timon, G.
    Romanelli, P.
    Rondi, E.
    Comi, S.
    Cattani, F.
    Matei, D. V.
    Ferro, M.
    Musi, G.
    Nole, F.
    De Cobelli, O.
    Ost, P.
    Orecchia, R.
    Jereczek-Fossa, B. A.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S719 - S720
  • [8] Should stereotactic ablative body radiotherapy be the standard of care in oligometastatic cancer?
    Correa, Rohann J. M.
    Palma, David A.
    [J]. LANCET ONCOLOGY, 2021, 22 (01): : 6 - 8
  • [9] What role does stereotactic ablative radiotherapy have in advanced castrate-resistant prostate cancer?
    Phillips, Ryan
    Ost, Piet
    Tran, Phuoc T.
    [J]. FUTURE ONCOLOGY, 2017, 13 (24) : 2121 - 2124
  • [10] Stereotactic ablative body radiotherapy in patients with prostate cancer
    Loblaw, Andrew
    Liu, Stanley
    Cheung, Patrick
    [J]. TRANSLATIONAL ANDROLOGY AND UROLOGY, 2018, 7 (03) : 330 - 340